Skip to content
Home » Pharmaceutical » BioNTech

BioNTech

vaccines COVID strokes

The bivalent COVID vaccines are not linked to strokes

The anti-vaccine world has jumped on some safety signals that seem to indicate that the bivalent COVID vaccines are linked to strokes. This group has shown how it misuses preliminary data to try to make false claims about every vaccine, especially the COVID-19 vaccines. This leads to false claims about these vaccines.

This post is going to examine what was found on VAERS, what is a safety signal, and what the FDA and CDC did to determine that there was no link between the bivalent COVID-19 vaccines and stroke. Even though this link has been dismissed, you just know that the anti-vaccine world will push it for the next few months.

Read More »The bivalent COVID vaccines are not linked to strokes
flu COVID-19 mRNA vaccine

Combination flu and COVID mRNA vaccine starting clinical trials

Pfizer and BioNTech have announced the start of a phase 1 clinical trial for a new mRNA vaccine that prevents both the flu and COVID-19. The new vaccine targets these two severe respiratory diseases with one jab.

Although during the past three years we have focused on the COVID-19 pandemic, the seasonal flu is also a dangerous disease. During the 2019-2020 flu season, the last one before COVID-19 mitigation efforts reduced the risk of flu, 390,000 Americans were hospitalized from the flu. And over 25,000 died.

So, a new mRNA vaccine (with all of its advantages to tailor the vaccine to the key antigens on the virus) that combines both flu and COVID-19 can be an effective weapon against these two diseases. In a couple of years, if all goes well, we will be able to get a season flu-COVID-19 mRNA vaccine that has been manufactured for the season’s prevalent variants of both diseases.

Let’s take a look at what we know about this new vaccine and the phase 1 clinical trial.

Read More »Combination flu and COVID mRNA vaccine starting clinical trials